Perspective on the Immunotherapy of Esophageal Cancer
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/13905_2021_2
Reference64 articles.
1. Gori S, Inno A, Belluomini L, Bocus P, Bisoffi Z, Russo A et al (2019) Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol 143:139–147. https://doi.org/10.1016/j.critrevonc.2019.09.003
2. Moehler M (2019) Checkpoint-Inhibitoren bei fortgeschrittenen ösophagogastralen Karzinomen Ist die Immuntherapie bereits kurz vor der Zulassung? Onkologie Heute 6:10–18
3. Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C et al (2013) Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 45(5):478
4. Fitzgerald RC, Abdalla S, Onwuegbusi BA, Sirieix P, Saeed IT, Burnham WR et al (2002) Inflammatory gradient in Barrett’s oesophagus: implications for disease complications. Gut 51(3):316–322
5. Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM et al (2005) Barrett’s oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 207(3):269–276. https://doi.org/10.1002/path.1847
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3